EcoR1 Capital’s Urovant Sciences Ltd. UROV Stock Holding History

EcoR1 Capital’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-26,468	Closed	-$411K	–	65
2019 Q4	$411K	Buy	+26,468	New	+$287K	0.04%	44

Other funds holding UROV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

EcoR1 Capital's UROV Position: Q1 2020 in Review

EcoR1 Capital sold out of Urovant Sciences Ltd. (UROV) in Q1 2020, closing a stake of 26,468 shares — an estimated $411K sold.

EcoR1 Capital first reported a position in UROV in Q4 2019 and held it in 1 quarter. The position peaked at $411K in Q4 2019. 24 funds tracked by Wall St. Rank hold UROV as of Q1 2020.

EcoR1 Capital reported no remaining Urovant Sciences Ltd. position as of Q1 2020 after selling out during the quarter.
EcoR1 Capital sold 26,468 Urovant Sciences Ltd. shares in Q1 2020, an estimated $411K.
EcoR1 Capital first reported a position in Urovant Sciences Ltd. in Q4 2019 and held it in 1 quarter.
EcoR1 Capital's Urovant Sciences Ltd. position peaked at $411K in Q4 2019.
24 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2020.

Based on EcoR1 Capital's 13F filing for Q1 2020, filed 15 May 2020.